GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
H

Halberd HALB · USD

N/A · US listing · 🇺🇸 United States

Compare

0.00

-2.78%

Close of 5 Nov 2026, in USD

Price performance

Chart by TradingView, with its own licensed prices

Halberd — daily HALB Delayed
Market value
$688,083
Last close × shares
Volume
5.8k
Shares, 5 Nov 2026

About Halberd

Its shares trade under the ticker HALB. It has been listed since 12 June 2009. In the fiscal year to 31 July 2024, it reported revenue of $999 and a net loss of $79,676. At that date it held total assets of $10,131 and shareholders' equity of −$718,588.

Halberd Corp. is a development stage company. The company is headquartered in Jackson Center, Pennsylvania. The company went IPO on 2009-06-12. The company is a research-based company that intends to discover and develop medical treatments for a wide range of diseases. The firm has developed extracorporeal treatment. The Company’s extracorporeal treatment is applicable to hard-to-cure blood-borne and neurologic diseases, including coronavirus disease of 2019 (Covid-19), other viruses, post-traumatic stress disorder (PTSD) and cancer.

Figures and description from our data supplier, not checked against the company's own report.

More about Halberd →

Latest on Halberd

Our reporting

We have not reported on Halberd yet.

Other N/A listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is Halberd's ticker?

Halberd trades as HALB on its US listing, under ISIN US4053311092.

What was Halberd's last closing price?

0.00 on 5 Nov 2026. The figure is in USD and is never converted.

Sources and methodology

Chart
TradingView
Close and company data
Our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.